(146 days)
No
The document explicitly states "Mentions AI, DNN, or ML: Not Found" and the device description focuses on hardware modifications and user interface updates, not advanced image processing or analytical capabilities typically associated with AI/ML in medical imaging.
No
The device is described as an "angiographic X-ray system" used for "diagnostic imaging and interventional procedures", which are diagnostic functions, not therapeutic.
Yes
The "Intended Use / Indications for Use" section explicitly states that the Trinias is "used for diagnostic imaging."
No
The device description clearly outlines modifications to hardware components such as user interfaces (wireless mouse, keyboard), a catheterization table, a digital system console, x-ray tube choices, digital flat panel detectors, and a control cabinet. This indicates it is a hardware system with associated software, not a software-only device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is an "angiographic X-ray system, which is used for diagnostic imaging and interventional procedures." This describes a system that uses X-rays to visualize blood vessels and perform procedures, which is an in vivo (within the living body) process.
- Device Description: The description details hardware components related to an X-ray system (user interfaces, catheterization table, digital system console, X-ray tube, flat panel detectors, control cabinet). These are all components of an imaging system used on a patient.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.) or performing tests in vitro (outside the living body).
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device operates directly on the patient using X-rays.
N/A
Intended Use / Indications for Use
The Trinias is an angiographic X-ray system, which is used for diagnostic imaging and interventional procedures. The Trinias is intended to be used for cardiac angiography, neurovascular angiography, abdominal angiography, peripheral angiography, rotational angiography, multi-purpose angiography and whole body radiographic/fluoroscopic procedures.
Product codes
OWB
Device Description
This notification is for a modified device. The modifications are: Updated user interfaces (wireless mouse, keyboard) A new model of catheterization table A new type of digital system console Additional x-ray tube choices Add alternate choices for the same sizes of digital flat panel detectors An additional size of available flat panel detector (12" x 16") An additional type of control cabinet. Model identifications: KS-70 Patient Table KS-100 New Patient Table F-100 New Collimator LX-6308, LX-6311, E79039X: X-ray Tubes DAR-9500f, Digital Angiography System; Flat panel. New MH-500 Suspended C-Arm New MH-600 Lateral C-Arm D150GC-40 High Voltage Generator
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-ray
Anatomical Site
Whole body
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not applicable. Clinical testing was not deemed to show substantial equivalence. We relied on non-clinical testing and compliance with standards.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1650 Image-intensified fluoroscopic x-ray system.
(a)
Identification. An image-intensified fluoroscopic x-ray system is a device intended to visualize anatomical structures by converting a pattern of x-radiation into a visible image through electronic amplification. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). An anthrogram tray or radiology dental tray intended for use with an image-intensified fluoroscopic x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9. In addition, when intended as an accessory to the device described in paragraph (a) of this section, the fluoroscopic compression device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
Shimadzu Corporation Medical Systems % Mr. Daniel Kamm Principal Engineer Kamm & Associates 8870 Ravello Ct NAPLES FL 34114
Re: K203535
Trade/Device Name: Trinias Regulation Number: 21 CFR 892.1650 Regulation Name: Image-intensified fluoroscopic x-ray system Regulatory Class: Class II Product Code: OWB Dated: March 29, 2021 Received: March 30, 2021
Dear Mr. Kamm:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see
April 28, 2021
1
https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-leam). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE(@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Michael D. O'Hara
For
Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
Device Name Trinias
Indications for Use (Describe)
The Trinias is an angiographic X-ray system, which is used for diagnostic imaging and interventional procedures. The Trinias is intended to be used for cardiac angiography, neurovascular angiography, abdominal angiography, peripheral angiography, rotational angiography, multi-purpose angiography and whole body radiographic/fluoroscopic procedures
| Type of Use (Select one or both, as applicable) | ||||
|---|---|---|---|---|
| X Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary: 510(k) Number K203535
4 SHIMADZU
Shimadzu Corporation 1, Nishinokyo-Kuwabaracho, Nakagyo-ku, Kyoto, 604-8511, Japan Registration Number: 8030233 Phone: +81-75-823-1305 Fax : +81-75-823-1377 Date Prepared: March 29, 2021 Contact: Shigeru Naganishi; Phone: +81-75-823-1920 E-mail: shige@shimadzu.co.jpshige@shimadzu.co.jp
1. Identification of the Device:
Trade/Device Names: Trinias Regulation Number: 21 CFR 892.1650 Regulation Name: Image-Intensified Fluoroscopic X-Ray System Regulatory Class: II Product Code: OWB Common/Usual Name: Interventional Fluoroscopic X-Ray System
2. Equivalent legally marketed device: K123508
Trade/Device Name: Trinias Manufacturer: Shimadzu. Regulation Number: 21CFR892.1650 Regulation Name: Interventional Fluoroscopic X-Ray System Regulatory Class: II Product Code: OWB Common/Usual Name: Interventional Fluoroscopic X-Ray System
-
- Indications for Use (intended use): The Trinias is an angiographic X-ray system, which is used for diagnostic imaging and interventional procedures. The Trinias is intended to be used for cardiac angiography, neurovascular angiography, abdominal angiography, peripheral angiography, rotational angiography, multi-purpose angiography and whole body radiographic/fluoroscopic procedures.
4. Description of the Device:
This notification is for a modified device. The modifications are: Updated user interfaces (wireless mouse, keyboard) A new model of catheterization table A new type of digital system console Additional x-ray tube choices Add alternate choices for the same sizes of digital flat panel detectors An additional size of available flat panel detector (12" x 16") An additional type of control cabinet. Model identifications: KS-70 Patient Table KS-100 New Patient Table F-100 New Collimator LX-6308, LX-6311, E79039X: X-ray Tubes DAR-9500f, Digital Angiography System; Flat panel. New MH-500 Suspended C-Arm
4
New MH-600 Lateral C-Arm D150GC-40 High Voltage Generator
-
- Safety and Effectiveness, comparison to predicate device. The results of bench and standards testing indicates that the new device is as safe and effective as the predicate device. Proper system operation is fully verified upon installation. Most of the components employed are identical to the predicate device.
| Trinias K123508 | Modified Trinias | |
|---|---|---|
| Indications for | ||
| Use: | The Trinias is an angiographic X-ray system, | |
| which is used for diagnostic imaging and | ||
| interventional procedures as described in 21 | ||
| CFR 892.1650. The Trinias is intended to be | ||
| used for cardiac angiography, neurovascular | ||
| angiography, abdominal angiography, | ||
| peripheral angiography, rotational | ||
| angiography, multi-purpose angiography and | ||
| whole body radiographic/fluoroscopic | ||
| procedures | The Trinias is an angiographic X-ray system, which | |
| is used for diagnostic imaging and interventional | ||
| procedures. The Trinias is intended to be used for | ||
| cardiac angiography, neurovascular angiography, | ||
| abdominal angiography, peripheral angiography, | ||
| rotational angiography, multi-purpose | ||
| angiography and whole body | ||
| radiographic/fluoroscopic procedures. (SAME | ||
| except CFR reference removed for international | ||
| consistency) | ||
| Patient Table | Image: KS-70 patient table | Newly available: KS-100, table top can tilt. |
| Image: KS-100 patient table | ||
| C-arms | ||
| Ceiling | Image: MH-200S C-arm | |
| MH-200S | Image: MH-500 C-arm | |
| MH-500 | ||
| Trinias K123508 | Modified Trinias | |
| Floor | MH-300 | |
| Image: MH-300 | MH-600 | |
| Image: MH-600 | ||
| MH-300/400 Biplane | ||
| Image: MH-300/400 Biplane | MH-300/400 Biplane is still available under | |
| K123508. | ||
| Digital X-Ray Receptor Panels Comparison | ||
| SIZE: | Shimadzu Reference/ | |
| Manufacturer Model | Shimadzu Reference/ | |
| Manufacturer Model | ||
| 9" x 9" | PANEL MAIN ASSY, A-9 | (No longer available) |
| 17" x 17" | PANEL MAIN ASSY, S-17 | (No longer available) |
| 8" x 8" | SFD-0808 | |
| Varex PaxScan 2020+ (194μm) | SFD-0808AF | |
| Varex PaxScan 2020X (194μm) (Updated version | ||
| of the predicate) | ||
| 12" x 12" | SFD-1212 | |
| Varex PaxScan 3030+ 194μm | SFD-1212AF | |
| Varex PaxScan 3030X (194μm) (Updated version | ||
| of the predicate) | ||
| 16" x 12" | This size was not available | SFD-1612AF |
| Varex PaxScan 4030X (194μm) (Updated version | ||
| of the predicate) | ||
| X-Ray Generation | ||
| Trinias K123508 | Modified Trinias | |
| Generator | 100 kW | SAME |
| Model # | D150GC-40 | Same as predicate |
| Control Method | 50kHz Inverter | Same as predicate |
| Rated output | 100kW | Same as predicate |
| Radiography tube Voltage | 40kV - 150kV | Same as predicate |
| Radiography tube current | 10 to 1250mA | Same as predicate |
| Radiography mAs | 0.5 to 800mAs | Same as predicate |
| Radiography time | 0.001 to 10sec | Same as predicate |
| Fluoroscopy tube voltage | 50kV to 125kV | Same as predicate |
| Fluoroscopy tube current | 0.3 to 30mA | 0.3 to 38mA |
| Short time rating | 100kv - 1000mA | Same as predicate |
| Long time rating | 100kv - 30mA | 100kV - 38mA |
| Collimator | F-50: Has 4 BH (beam hardening) filters with Irradiation area of 400 x 400 mm max | F-100: Has 16 BH filters with irradiation area of 421 x 421 mm max. New collimator offers more filtration options. |
| Safety Standards | ||
| US Performance Standard | 21CFR1020.30, 21CFR1020.31 and 21CFR2020.32 | SAME |
| IEC Safety Standards | See list below | SAME |
6. Substantial Equivalence Chart: Below.
5
6
-
- Summary of non-clinical testing: Software was validated according to the FDA Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Document issued on: May 11, 2005. Because the system uses Wi-Fi and Ethernet, we observed the recommendations contained in the FDA Guidance Document: Content of Premarket Submissions for Management of Cybersecurity in Medical Devices Guidance for Industry and Food and Drug Administration Staff Document Issued on: October 2, 2014. The digital panel software employed was already reviewed by FDA. Labeling was developed and information provided in accordance with this FDA Guidance Document: Pediatric Information for X-ray Imaging Device Premarket Notifications, Guidance for Industry and Food and Drug Administration Staff, November 2017. Labeling also includes reference to the Image Gently website (http://www.imagegently.org/). Because the device contains wireless technology, we consulted Radio Frequency Wireless Technology in Medical Devices - Guidance for Industry and FDA Staff, AUGUST 2013 and we incorporated those recommendations into our labeling.
7
This device has been tested and is certified to comply with the US Radiation Safety Performance Standards as listed in the table above. Performance and safety testing was conducted by third party NRTL certified testing laboratories and the device was found to comply with the following FDA recognized standards:
- US Performance Standard 21CFR1020.30, 21CFR1020.31 and 21CFR2020.32 .
- IEC 60601-1: 2005 + CORR. 1:2006 + CORR. 2:2007 + AM1:2012 Medical electrical equipment Part . 1: General requirements for basic safety and essential performance FDA 19-4
- 0 IEC 60601-1-2:2014 Collateral Standard: Electromagnetic disturbances - Requirements and tests FDA 19-8
- 9 IEC 60601-1-3:2008 + A1:2013 Medical electrical equipment - Part 1-3: General requirements for basic safety and essential performance - Collateral Standard: Radiation protection in diagnostic Xray equipment FDA 12-269
- . IEC 60601-1-6:2010 + A1:2013 Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability FDA 5-89
- IEC 60601-2-43:2010 + A1:2017 Particular requirements for the basic safety and essential . performance of X-ray equipment for interventional procedures FDA 12-308
- Additionally evaluated in accordance with .
- IEC 62366: 2007 + A1: 2014 Medical devices Part 1: Application of usability engineering to medical 0 devices FDA 5-114
- IEC 62304: 2006 Medical device software Software life cycle processes FDA 13-79 .
- . EN 60601-1:2006 + A11:2011 + A1:2013 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance
- . EN 60601-1-3:2008 + A1:2013 + A11:2016 Medical electrical equipment - Part 1-3: General requirements for basic safety and essential performance - Collateral Standard: Radiation protection in diagnostic X-ray equipment
- . EN 60601-1-6:2010 + A1:2015 Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability
- EN 60601-2-43:2010 + A1:2018 Medical electrical equipment Part 1-6: General requirements for . basic safety and essential performance - Collateral standard: Usability
- . EN 62304:2006 Medical device software - Software life cycle processes
- ANSI/AAMI ES60601-1:2005 + A2:2010 + A1:2012 .
We consulted the following FDA guidance documents in the development of the Trinias: Content of Premarket Submissions for Management of Cybersecurity in Medical Devices, Guidance for Industry and Food and Drug Administration Staff; and Pediatric Information for X-ray Imaging Device Premarket Notifications.
-
- Summary of clinical testing: Not applicable. Clinical testing was not deemed to show substantial equivalence. We relied on non-clinical testing and compliance with standards.
-
- Conclusion: After analyzing standards compliance results and bench tests, it is the conclusion of Shimadzu Corporation that the MODIFIED Trinias is as safe and effective as the predicate device, has few technological differences, and has the same indications for use, thus rendering it substantially equivalent to the predicate device.